SCHEMBL7907251

SCHEMBL7907251

CC(C)(C)OC(=O)N(N)c1ccc(N2C(=O)C=CC2=O)cn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.35
HSP90AA1 P07900 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
HTT P42858 2/20 0.35
CACNA1B Q00975 1/20 0.35
APBA1 Q02410 1/20 0.35
MGLL Q99685 10/20 0.34
FAAH O00519 3/20 0.34
DDAH1 O94760 1/20 0.34
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
G6PD P11413 1/20 0.33
TLR9 Q9NR96 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8726598 0.93 ALDH1A1 (0.33) NPSR1HSP90AA1TDP1ALDH1A1HPGD
SCHEMBL8723112 0.77 KDM4E (0.34) ALDH1A1PTGS1GPR119
SCHEMBL2558802 0.75 HCAR3 (0.48) ALDH1A1HPGDMAPT
SCHEMBL7913868 0.72 CYP2C19 (0.49) ALDH1A1HTTPKMLMNAMAPT
SCHEMBL1509166 0.71 CRBN (0.36) MAPK1GPR119
SCHEMBL7907253 0.70 GAA (0.40) NPSR1HSP90AA1TDP1ALDH1A1HPGD
SCHEMBL8126885 0.70 POLB (0.47) NPSR1HTTMAPK1LMNAMAPT
SCHEMBL28781892 0.70 MEN1 (0.34) ALDH1A1NFKB1NFKB2RELAMAPT
SCHEMBL8726600 0.68 GAA (0.38) NPSR1HSP90AA1TDP1ALDH1A1HPGD
SCHEMBL27838787 0.67 POLB (0.38) ALDH1A1HTTNFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6217845-B1 IMAGING; THERAPY ANORMED, INC. (CA) 2001-04-17 US disclosed
US-5753520-A BIOCHEMICAL CONJUGATED WITH A HYDRAZINE OR A HYDRAZONE COMPOUND AS DRUG DELIVERY; HIGH BIOLOGICAL SPECIFICITY; MEDICINE FOR IMAGING, THERAPY, RADIOACTIVE TAGGING JOHNSON MATTHEY INC. (US) 1998-05-19 US disclosed
EP-0384769-B1 Protein labelling JOHNSON MATTHEY PLC (GB) 1996-04-24 EP disclosed
US-5420285-A Imaging for medicine JOHNSON MATTHEY, INC. (US) 1995-05-30 US disclosed
US-5206370-A Certain pyridyl hydrazines and hydrazides useful for protein labeling JOHNSON MATTHEY, INC. (US) 1993-04-27 US disclosed
EP-0384769-A2 Protein labelling JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 1990-08-29 EP disclosed